UPCC 29124 Recurrence score assay in ATM and CHEK2-associated versus sporadic breast cancers

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

Obtain patient information (name, age, gender, genetic testing information, OncoType Dx recurrence scores, breast cancer diagnosis information (hormone receptor status, TNM, histology), age at diagnosis) collected from the electronic medical record of approximately 70 patients to perform age-matched control analyses.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 853041
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator